eRAPID Feasibility Pilot Study in Pelvic Radiotherapy

NACompletedINTERVENTIONAL
Enrollment

167

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

June 1, 2018

Study Completion Date

October 30, 2018

Conditions
Cancer
Interventions
DEVICE

eRAPID

eRAPID is an online system for patients to self-report symptoms and AE during and after cancer treatments. eRAPID allows AE reporting from home or hospital and enables patient reported data to be integrated into existing EPR to allow for the reports to be used in routine care. In addition the system is capable of generating alerts for severe AE to the relevant clinical team and providing patient advice on managing mild and moderate AE.

Trial Locations (2)

M204BX

The Christie Hospital, Manchester

LS97TF

St James University Hospital, Leeds

All Listed Sponsors
collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

The Christie NHS Foundation Trust

OTHER

lead

University of Leeds

OTHER

NCT02747264 - eRAPID Feasibility Pilot Study in Pelvic Radiotherapy | Biotech Hunter | Biotech Hunter